THERA NEUROPHARMA Trademark
Trademark Overview
On Monday, January 7, 2019, a trademark application was filed for THERA NEUROPHARMA with the United States Patent and Trademark Office. The USPTO has given the THERA NEUROPHARMA trademark a serial number of 88251570. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 6, 2026. This trademark is owned by Thera Neuropharma, Inc.. The THERA NEUROPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical laboratory services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Scientific research for medical purposes in the field of pharmaceuticals for the diagnosis and treatment of central nervous systems and neurological conditions and disorders; Technical consulting in the field of pharmaceutical studies; Medical and scientific research in the field of central nervous system and neurological conditions and disorders
General Information
| Serial Number | 88251570 |
| Word Mark | THERA NEUROPHARMA |
| Filing Date | Monday, January 7, 2019 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, February 6, 2026 |
| Registration Number | 5812691 |
| Registration Date | Tuesday, July 23, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 7, 2019 |
Trademark Statements
| Pseudo Mark | THERA NEURON PHARMACY |
| NOT AVAILABLE | "NEUROPHARMA" |
| Goods and Services | Medical laboratory services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Scientific research for medical purposes in the field of pharmaceuticals for the diagnosis and treatment of central nervous systems and neurological conditions and disorders; Technical consulting in the field of pharmaceutical studies; Medical and scientific research in the field of central nervous system and neurological conditions and disorders |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, February 6, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, May 1, 2016 |
| First Use In Commerce Date | Sunday, May 1, 2016 |
Trademark Owner History
| Party Name | Thera Neuropharma, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Berwin, PA 19312 |
| Party Name | Thera Neuropharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Berwin, PA 19312 |
| Party Name | Thera Neuropharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Berwin, PA 19312 |
Trademark Events
| Event Date | Event Description |
| Thursday, January 10, 2019 | NEW APPLICATION ENTERED |
| Sunday, January 27, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, March 23, 2019 | ASSIGNED TO EXAMINER |
| Saturday, March 23, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 17, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 7, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 7, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 23, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 23, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, February 6, 2026 | CANCELLED SEC. 8 (6-YR) |
